← Open Payments lookup

SHAHID INSAF: Open Payments

NPI 1174666044 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$172,074 in 319 payments from 21 companies in 2025. Trend: 2023 $69,402 · 2024 $97,910 · 2025 $172,074

Honoraria: $71,650Speaker / faculty: $48,440Travel & lodging: $30,777Consulting: $13,168Food & beverage: $8,028Education: $11
CompanyPaymentsAmount
Axsome Therapeutics, Inc.58$53,094
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)45$51,011
Supernus Pharmaceuticals, Inc.82$38,250
Alkermes, Inc.40$25,612
E.R. Squibb & Sons, L.L.C.23$1,941
ABBVIE INC.9$499
Otsuka America Pharmaceutical, Inc.12$355
Neurocrine BioSciences, Inc.13$333
Vanda Pharmaceuticals Inc.12$257
Collegium Pharmaceutical, Inc.3$171

Products named: Auvelity, CAPLYTA, Qelbree, LYBALVI, COBENFY, VRAYLAR, INGREZZA, REXULTI.

Industry payments across MO — which companies pay providers there.